… bleeding with potent antiplatelet agents after an acute coronary event: a comparison of ticagrelor and clopidogrel in 5116 consecutive patients in clinical practice
… recognized end points for myocardial infarction and bleeding, … from clopidogrel paired with
aspirin to ticagrelor with aspirin … consented patients, as is standard in randomized controlled …
aspirin to ticagrelor with aspirin … consented patients, as is standard in randomized controlled …
… clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: rationale and design of the TicagRElor in pAtients with ST elevation myocardial …
… ) traditionally consisting of aspirin plus clopidogrel has been … Trial (COMMIT) 5 randomized
45,852 patients with acute MI (87… clopidogrel 75 mg daily or matching placebo in addition to …
45,852 patients with acute MI (87… clopidogrel 75 mg daily or matching placebo in addition to …
… aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: an analysis of 15 000 patients …
HL Lee, JT Kim, JS Lee, MS Park, KH Choi… - … Quality and Outcomes, 2020 - Am Heart Assoc
… (ischemic and hemorrhagic), myocardial infarction (MI), and all-cause … In the present study,
≈45% of the patients with mild-to-… Additional randomized controlled trials are warranted to …
≈45% of the patients with mild-to-… Additional randomized controlled trials are warranted to …
[HTML][HTML] Ticagrelor with or without aspirin in high-risk patients after PCI
… We conducted this randomized, placebo-controlled trial in … of death, myocardial infarction,
or stroke among patients who … incidence of bleeding than clopidogrel plus aspirin, without an …
or stroke among patients who … incidence of bleeding than clopidogrel plus aspirin, without an …
… versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised …
BK Koo, J Kang, KW Park, TM Rhee, HM Yang… - The Lancet, 2021 - thelancet.com
… ), clinical presentation (acute myocardial infarction or not and acute coronary syndrome or
not), … between both groups (852 [31·4%] vs 882 [32·3%]). Detailed clinical diagnosis of these …
not), … between both groups (852 [31·4%] vs 882 [32·3%]). Detailed clinical diagnosis of these …
… -based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized …
… patients into 3 groups: DAT (aspirin and clopidogrel for 12 … In total, 852 enrolled patients
(90%) were followed up … that the addition of cilostazol to DAT may not provide additional benefits …
(90%) were followed up … that the addition of cilostazol to DAT may not provide additional benefits …
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
… adding clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: the Clopidogrel
… with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:…
… with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:…
… genotypes on platelet reactivity and early cardiovascular outcomes in patients undergoing percutaneous coronary intervention and treated with aspirin and clopidogrel
K Xu, S Ye, S Zhang, M Yang, T Zhu… - Circulation …, 2019 - Am Heart Assoc
… composite of cardiovascular death, nonfatal myocardial infarction, and ischemic stroke were
… dose of clopidogrel or aspirin in AA homozygotes will provide little additional benefit, which …
… dose of clopidogrel or aspirin in AA homozygotes will provide little additional benefit, which …
[HTML][HTML] Dual antiplatelet therapy in patients with high cardiovascular risk
C Espinoza, D Mukherjee - Heart International, 2021 - ncbi.nlm.nih.gov
… , non-fatal stroke, myocardial infarction (MI) or major bleeding … patients with a history of
ischaemic stroke were randomized … stroke/TIA, short-course clopidogrel plus aspirin for 21 days …
ischaemic stroke were randomized … stroke/TIA, short-course clopidogrel plus aspirin for 21 days …
Efficacy and safety of clopidogrel, prasugrel and ticagrelor in ACS patients treated with PCI: a propensity score analysis of the RENAMI and BleeMACS registries
M Peyracchia, A Saglietto, C Biole… - American Journal of …, 2020 - Springer
… in terms of recurrent myocardial infarction (MI) and bleedings. This … aspirin in addition to
clopidogrel, ticagrelor, or prasugrel. … analyzed, was in accord with a recent randomized trial [15]. …
clopidogrel, ticagrelor, or prasugrel. … analyzed, was in accord with a recent randomized trial [15]. …